Discover six bispecific antibody companies developing a two-in-one approach to delivering targeted therapeutics to patients.

Since Abcam's acquisition in 2023, founder Jonathan Milner has been making waves with his investment strategy. Discover his ...

A biotech startup’s journey to unicorn status hinges on its leadership and the culture fostered within the organization. A ...

Therapeutic strides in biotech are advancing promising candidates in clinic to address different stages of sleep apnea and ...

Advanced therapy medicinal products (ATMPs) are pushing the boundaries of medicine, offering hope for previously untreatable conditions. But as Europe’s ATMP landscape grows, the challenge of safely ...

Exosomes are extracellular vesicles around 30 to 150 nanometers across that are generated by all cells and play crucial roles in fundamental cellular processes, such as the regeneration of damaged ...